Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05759949
Title First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Relay Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at Florida Cancer Specialists Orlando Florida 32827 United States Details
Community Cancer Center North Indianapolis Indiana 46250 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Memorial Sloan Kettering Cancer Center-Main Campus New York New York 10065 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field